| Literature DB >> 33984226 |
Nayansi Jha1, Yoon-Ji Kim2, Youngjun Lee3, Ju Young Lee4, Won Jin Lee5, Sang-Jin Sung2.
Abstract
OBJECTIVE: To estimate the projected cancer risk attributable to diagnostic cone-beam computed tomography (CBCT) performed under different exposure settings for orthodontic purposes in children and adults.Entities:
Keywords: Cancer risk; Cone-beam computed tomography; Ionizing radiation; Lifetime fractional ratio
Year: 2021 PMID: 33984226 PMCID: PMC8133899 DOI: 10.4041/kjod.2021.51.3.189
Source DB: PubMed Journal: Korean J Orthod Impact factor: 1.372
Descriptive statistics for the exposure parameters of cone-beam computed tomography machines analyzed in the study
| Statistics | kVp | mA | Exposure time (s) |
|---|---|---|---|
| Mean ± standard deviation | 94.0 ± 18.3 | 7.7 ± 2.6 | 20.2 ± 5.3 |
| Range | 80–130 | 5–16 | 9–24 |
| Median | 105 | 9.5 | 16.5 |
kVp, peak kilovoltage; mA, milliapmere; s, seconds.
Figure 1ALARA-Dental software (Kyung Hee University, Seoul, Korea, and Korea Centers for Disease Control and Prevention, Cheongju, Korea)[13] for estimating organ doses delivered for the acquisition of dental radiographs, including intraoral radiographs, panoramic radiographs, and cone-beam computed tomography images.
Figure 2Estimation of cancer risk from cone-beam computed tomography for orthodontic purposes using the radiation risk assessment tool (RadRAT version 4.1.1; National Institutes of Health, Bethesda, MD, USA).[18]
Estimated mean organ doses (mGy) under median and maximum exposure settings for cone-beam computed tomography performed for orthodontic purposes in children aged 5 and 10 years and adults
| Exposed organ | Median exposure | Maximum exposure | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Children | Adults | Adults | Children | Adults | Adults | ||||
| 5 years | 10 years | 5 years | 10 years | ||||||
| Brain | 33.3 | 28.4 | 18.7 | 26.5 | 69.4 | 59.5 | 23.0 | 32.2 | |
| Salivary glands | 40.9 | 42.2 | 39.6 | 39.0 | 82.1 | 84.0 | 41.3 | 40.2 | |
| Oral mucosa | 43.4 | 33.3 | 23.3 | 25.0 | 89.9 | 70.7 | 28.2 | 29.5 | |
| Esophagus | 4.5 | 1.7 | 0.4 | 0.6 | 9.3 | 3.6 | 0.5 | 0.7 | |
| Thyroid | 9.2 | 5.2 | 3.1 | 3.2 | 18.5 | 10.8 | 4.2 | 3.4 | |
| Skin | 21.1 | 12.1 | 3.1 | 3.8 | 40.3 | 23.1 | 3.0 | 3.7 | |
| Thymus | 1.8 | 1.0 | 0.4 | 0.9 | 4.1 | 2.2 | 0.7 | 1.0 | |
| Thoracic airway | 3.8 | 2.0 | 0.9 | 1.1 | 7.7 | 4.1 | 1.2 | 1.4 | |
| Skeletal muscle | 4.1 | 2.0 | 1.1 | 2.2 | 8.1 | 4.1 | 1.2 | 2.3 | |
| Bone surface | 11.6 | 5.1 | 1.6 | 1.6 | 24.6 | 10.9 | 4.2 | 9.1 | |
| Red bone marrow | 10.5 | 5.4 | 3.3 | 4.3 | 22.3 | 11.6 | 2.0 | 10.1 | |
| Remainder organ & tissues | 2.2 | 2.9 | 2.0 | 2.2 | 8.5 | 6.2 | 2.4 | 2.6 | |
| Total | 186.6 | 141.5 | 97.3 | 110.5 | 384.8 | 290.9 | 111.9 | 136.4 | |
M, male, F, female.
*Median exposure settings: kVp, 105; mAs, 156.8; field of view, 19 × 20 cm; filter thickness, 2 mm.
†Maximum exposure settings: kVp, 130; mAs, 200; field of view, 19 × 20 cm; filter thickness, 2 mm.
‡Organ doses for boys and girls are equal.
Figure 3Distribution of mean organ doses (mGy) delivered by cone-beam computed tomography performed for orthodontic purposes in children and adults.
Lifetime attributable risk (LAR)* for site-specific cancers and all cancers according to median exposure settings† for cone-beam computed tomography performed for orthodontic purposes in children and adults
| Age | No. of | Sex | LAR (n) | LBR | LFR | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral cavity & pharynx | Esophagus | Lung | Nervous system | Thyroid | Other & ill-defined sites | Leukemia | All cancers (total) | |||||
| 5 | 1 | F | 44 | 1 | 13 | 7 | 690 | 260 | 15 | 1,030 | 18,430 | 5.59 |
| 5 | 1 | M | 50 | 4 | 7 | 24 | 72 | 307 | 20 | 482 | 19,313 | 2.50 |
| 5 | 2 | F | 86 | 1 | 26 | 14 | 1,330 | 512 | 29 | 1,990 | 18,430 | 10.80 |
| 5 | 2 | M | 97 | 97 | 8 | 14 | 48 | 138 | 605 | 946 | 19,313 | 4.90 |
| 5 | 3 | F | 130 | 2 | 39 | 21 | 2,020 | 772 | 44 | 3,020 | 18,430 | 16.39 |
| 5 | 3 | M | 147 | 147 | 12 | 20 | 72 | 210 | 912 | 1,430 | 19,310 | 7.41 |
| 10 | 1 | F | 32 | 0 | 6 | 4 | 257 | 106 | 5 | 408 | 18,394 | 2.22 |
| 10 | 1 | M | 36 | 1 | 3 | 16 | 27 | 124 | 7 | 210 | 19,270 | 1.09 |
| 10 | 2 | F | 62 | 0 | 12 | 8 | 493 | 208 | 10 | 791 | 18,394 | 4.30 |
| 10 | 2 | M | 70 | 2 | 6 | 30 | 51 | 243 | 14 | 411 | 19,270 | 2.13 |
| 10 | 3 | F | 94 | 1 | 17 | 13 | 750 | 314 | 15 | 1,200 | 18,390 | 6.53 |
| 10 | 3 | M | 106 | 4 | 9 | 45 | 78 | 368 | 21 | 621 | 19,270 | 3.22 |
| 20 | 1 | F | 18 | 0 | 4 | 2 | 68 | 30 | 3 | 123 | 18,273 | 0.67 |
| 20 | 1 | M | 19 | 0 | 1 | 5 | 7 | 26 | 3 | 60 | 19,173 | 0.31 |
| 20 | 2 | F | 34 | 0 | 7 | 4 | 130 | 59 | 5 | 239 | 18,273 | 1.31 |
| 20 | 2 | M | 38 | 0 | 2 | 9 | 13 | 52 | 5 | 118 | 19,173 | 0.62 |
| 20 | 3 | F | 52 | 0 | 11 | 7 | 198 | 88 | 8 | 362 | 18,273 | 1.98 |
| 20 | 3 | M | 57 | 1 | 3 | 14 | 20 | 78 | 8 | 178 | 19,173 | 0.93 |
| 30 | 1 | F | 12 | 0 | 3 | 1 | 27 | 21 | 2 | 65 | 17,619 | 0.37 |
| 30 | 1 | M | 13 | 0 | 1 | 3 | 3 | 18 | 2 | 39 | 19,035 | 0.21 |
| 30 | 2 | F | 23 | 0 | 5 | 3 | 51 | 40 | 4 | 126 | 17,619 | 0.72 |
| 30 | 2 | M | 26 | 0 | 1 | 6 | 5 | 35 | 5 | 77 | 19,035 | 0.41 |
| 30 | 3 | F | 34 | 0 | 8 | 4 | 78 | 61 | 7 | 191 | 17,619 | 1.08 |
| 30 | 3 | M | 39 | 0 | 2 | 9 | 8 | 54 | 7 | 117 | 19,035 | 0.61 |
| 40 | 1 | F | 3 | < 0 | 1 | 0 | 2 | 3 | 1 | 18 | 15,977 | 0.11 |
| 40 | 1 | M | 1 | 0 | 0 | 1 | 0 | 5 | 1 | 16 | 18,670 | 0.09 |
| 40 | 2 | F | 5 | < 0 | 2 | 1 | 4 | 6 | 2 | 35 | 15,977 | 0.22 |
| 40 | 2 | M | 3 | 0 | 0 | 1 | 0 | 10 | 2 | 33 | 18,670 | 0.18 |
| 40 | 3 | F | 8 | < 0 | 4 | 1 | 6 | 8 | 2 | 52 | 15,977 | 0.33 |
| 40 | 3 | M | 4 | 0 | 1 | 2 | 1 | 15 | 2 | 49 | 18,670 | 0.26 |
LBR, lifetime baseline risk; LFR, lifetime fractional ratio; exp, radiation exposure; F, female; M, male.
*Lifetime risk of cancer due to radiation (estimated number of new cases per 100,000 people), with a 90% uncertainty range.
†Median exposure settings: kVp, 105; mAs, 156.8; field of view, 19 × 20 cm; filter thickness, 2 mm.
‡LAR of all cancers.
Lifetime attributable risk (LAR)* for site-specific cancers and all cancers according to maximum exposure settings† for cone-beam computed tomography performed for orthodontic purposes in children and adults
| Age | No. of exp | Sex | LAR (n) | LBR | LFR | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral cavity & pharynx | Esophagus | Lung | Nervous system | Thyroid | Other & ill-defined sites | Leukemia | All cancers (total) | |||||
| 5 | 1 | F | 92 | 2 | 29 | 16 | 1,450 | 576 | 33 | 2,190 | 18,430 | 11.88 |
| 5 | 1 | M | 104 | 8 | 15 | 58 | 154 | 687 | 43 | 1,060 | 19,310 | 5.49 |
| 5 | 2 | F | 181 | 3 | 58 | 32 | 2,780 | 1,130 | 62 | 4,250 | 18,430 | 23.06 |
| 5 | 2 | M | 204 | 16 | 30 | 113 | 295 | 1,350 | 83 | 2,090 | 19,310 | 10.82 |
| 5 | 3 | F | 270 | 5 | 86 | 48 | 4,120 | 1,690 | 92 | 6,300 | 18,430 | 34.18 |
| 5 | 3 | M | 304 | 24 | 44 | 169 | 436 | 2,020 | 123 | 3,110 | 19,310 | 16.11 |
| 10 | 1 | F | 68 | 1 | 13 | 10 | 535 | 243 | 11 | 876 | 18,394 | 4.76 |
| 10 | 1 | M | 77 | 3 | 7 | 37 | 56 | 284 | 16 | 469 | 19,270 | 2.43 |
| 10 | 2 | F | 151 | 3 | 48 | 24 | 1,840 | 958 | 42 | 3,050 | 18,390 | 16.59 |
| 10 | 2 | M | 170 | 14 | 25 | 86 | 195 | 1,130 | 58 | 1,650 | 19,270 | 8.56 |
| 10 | 3 | F | 225 | 4 | 71 | 35 | 2,720 | 1,430 | 62 | 4,530 | 18,390 | 24.63 |
| 10 | 3 | M | 254 | 20 | 37 | 126 | 288 | 1,690 | 86 | 2,470 | 19,270 | 12.82 |
| 20 | 1 | F | 19 | 0 | 4 | 3 | 72 | 56 | 7 | 307 | 18,273 | 1.68 |
| 20 | 1 | M | 22 | 0 | 1 | 6 | 9 | 37 | 2 | 76 | 19,173 | 0.40 |
| 20 | 2 | F | 38 | 0 | 8 | 5 | 139 | 110 | 13 | 312 | 18,273 | 1.71 |
| 20 | 2 | M | 43 | 1 | 3 | 12 | 18 | 72 | 3 | 150 | 19,173 | 0.78 |
| 20 | 3 | F | 57 | 0 | 13 | 8 | 205 | 165 | 19 | 464 | 18,273 | 2.54 |
| 20 | 3 | M | 64 | 1 | 4 | 17 | 26 | 108 | 5 | 223 | 19,173 | 1.16 |
| 30 | 1 | F | 13 | 0 | 3 | 2 | 29 | 39 | 5 | 90 | 17,619 | 0.51 |
| 30 | 1 | M | 15 | 0 | 1 | 4 | 4 | 25 | 1 | 50 | 19,035 | 0.26 |
| 30 | 2 | F | 25 | 0 | 6 | 4 | 55 | 76 | 11 | 175 | 17,619 | 0.99 |
| 30 | 2 | M | 29 | 0 | 2 | 7 | 7 | 50 | 3 | 97 | 19,035 | 0.51 |
| 30 | 3 | F | 37 | 0 | 9 | 5 | 81 | 114 | 16 | 260 | 17,619 | 1.48 |
| 30 | 3 | M | 43 | 1 | 3 | 11 | 11 | 74 | 4 | 145 | 19,035 | 0.76 |
| 40 | 1 | F | 11 | 0 | 3 | 1 | 10 | 34 | 5 | 63 | 15,977 | 0.39 |
| 40 | 1 | M | 13 | 0 | 1 | 3 | 1 | 22 | 1 | 41 | 18,670 | 0.22 |
| 40 | 2 | F | 21 | 0 | 5 | 3 | 19 | 68 | 10 | 125 | 15,977 | 0.78 |
| 40 | 2 | M | 25 | 0 | 2 | 6 | 2 | 45 | 3 | 82 | 18,670 | 0.44 |
| 40 | 3 | F | 32 | 0 | 8 | 4 | 28 | 102 | 15 | 187 | 15,977 | 1.17 |
| 40 | 3 | M | 38 | 1 | 3 | 9 | 4 | 67 | 4 | 124 | 18,670 | 0.66 |
LBR, lifetime baseline risk; LFR, lifetime fractional ratio; exp, radiation exposure; F, female; M, male.
*Lifetime risk of developing cancer due to radiation (estimated number of new cases per 100,000 people), with a 90% uncertainty range.
†Maximum exposure settings: kVp, 130; mAs, 200; field of view, 19 × 20 cm; filter thickness, 2 mm.
‡LAR of all cancers.
Figure 4Mean lifetime fractional ratio (LFR) after a single exposure under maximum and median exposure settings, according to age.
Figure 5Comparison of the mean lifetime fractional ratio (LFR) after a single exposure under maximum exposure settings between male and female patients in different age groups.
Figure 6Comparison of mean lifetime attributable risk (LAR) values after a single exposure under maximum exposure parameters between adults and children, according to the cancer site.